Home

Teva Pharmaceutical Industries - Financial Overview

Ticker - TEVA

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$13.65$15.66B-4.9N/A-2.6%2.9

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2020-12-31 $16.7B $-4.0B $-3.64 N/A N/A N/A
1 2021-12-31 $15.9B $417.0M $0.38 -4.7% -110.5% -110.4%
2 2022-12-31 $14.9B $-2.4B $-2.12 -6.0% -686.6% -657.9%
3 2023-12-31 $15.8B $-559.0M $-0.50 6.2% -77.1% -76.4%
4 2024-12-31 $16.5B $-1.6B $-0.50 4.4% 193.2% 0.0%
5 TTM 2024-12-31 $16.5B $-1.6B $-1.45 -0.0% 0.0% 190.0%
6 Average -0.0% -136.2% -130.9%




TEVA - Forecast Data



TEVA - Y/Y % Change

  Metric Value
0 Total Assets $39,326M
1 Cash $3,300M
2 Total Liabilities $33,606M
3 Total Debt $18,079M
4 Total Equity $5,373M
5 Debt to Equity Ratio 3.36
TEVA Balance Sheet Chart



TEVA - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S
$13.65 4.3% Nicks Growth: 0%
Nick's Expected Margin: 5%
FINVIZ Growth: 6%
Nicks: 6
Finviz: 12
Nick's: 0.323 0.9
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$14.42 RevPS TTM $4.66 -65.9% $8.77 -35.8%
$2.55 EPS 2025 $16.47 20.7% $31.02 127.3%
$2.65 EPS 2026 $17.11 25.3% $32.24 136.2%